Shares of Altimmune, Inc. (NASDAQ:ALT – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the nine ratings firms that are presently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy […]

Abacus Life, Inc. (NASDAQ:ABL – Get Free Report) has received an average rating of “Buy” from the six brokerages that are presently covering the company, MarketBeat reports. Five investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among […]